Abstract
African Americans have the highest mortality for the top five causes of cancer death. The reasons for these and other cancer disparities are not easily explained, but a better understanding of current hypotheses and best practices may improve your patient’s outcomes. A study of almost 20,000 cancer patients found that “when controlled for uniform stage, treatment, and follow up, African American sex-specific cancers (breast, ovarian, and prostate) still did worse.” The colon cancer incidence and death rate is so high in the African American community that the American College of Gastroenterology recommends screening begin at age 45. Studies also showed an increased occurrence in African Americans for right-sided colon cancer tumors prompting recommendations against sigmoidoscopy in these patients because a majority of tumors would be missed. Prostate cancer in African American men is the most prevalent occurring cancer, and the second most common cause of overall cancer deaths. European American male smokers consume 30%–40% more cigarettes than their African American counterparts, but African American male smokers are 34% more likely to develop lung cancer. These and other curious cancer differences are more closely examined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
QuickStats: age-adjusted death rates for top five causes of cancer death, by Race/Hispanic Ethnicity — United States. MMWR Morb Mortal Wkly Rep. 2016;65:989. https://doi.org/10.15585/mmwr.mm6536a10.
Centers for Disease Control and Prevention. Breast cancer rates among black and white women. https://www.cdc.gov/cancer/dcpc/research/articles/breast_cancer_rates_women.htm.
American Cancer Society. Breast cancer facts & figures 2017–2018. Atlanta: American Cancer Society, Inc; 2017.
Albain K, Unger J, Crowley J, Coltman C, Hershman D. Racial disparities in cancer survival among randomized clinical trials patients of the southwest oncology group. J Natl Cancer Inst. 2009;101(14):984–92.
Newman L, Stark A, Chitale D, et al. Association between benign breast disease in African American and white American women and subsequent triple-negative breast Cancer. JAMA Oncol. 2017;3(8):1102–6.
Bazargan M, Lucas-Wright A, Jones L, et al. Understanding perceived benefit of early cancer detection: community-partnered research with African American women in South Los Angeles. J Women’s Health (Larchmt). 2015;24(9):755–61.
Ananthakrishnan A, Schellhase K, Sparapani R, Laud P, Neuner J. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007;167(3):258–64.
Rex D, Johnson D, Anderson J, et al. Colorectal cancer screening. Am J Gastroenterol. 2009;104:739–50.
Paquette I, Ying J, Shah S, Abbott D, Ho S. African Americans should be screened at an earlier age for colorectal cancer. Gastrointest Endosc. 2015;82(5):878–83.
Chattar-Cora D, Onime G, Valentine I, Cudjoe E, Rivera L. Colorectal cancer in a multi-ethnic urban group: its anatomical and age profile. Int Surg. 2000;85(2):137–42.
Fedewa S, Flanders W, Ward K, et al. Racial and ethnic disparities in interval colorectal cancer incidence: a population-based cohort study. Ann Intern Med. 2017;166(12):857–66.
Myers R, Sifri R, Daskalakis C, et al. Increasing colon cancer screening in primary care among African Americans. J Natl Cancer Inst. 2014;106(12):dju344.
Myers R, Bittner-Fagan H, Daskalakis C, et al. A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening. Cancer Epidemiol Biomark Prev. 2013;22(1):109–17.
Rawl S, Skinner C, Perkins S, et al. Computer-delivered tailored intervention improves colon cancer screening knowledge and health beliefs of African Americans. Health Educ Res. 2012;27(5):868–85.
Jerant A, Sohler N, Fiscella K, et al. Tailored interactive multimedia computer programs to reduce health disparities: opportunities and challenges. Patient Edu Couns. 2011;85:323–30.
U.S. Preventative Services Task Force. Published final recommendations. https://www.uspreventiveservicestaskforce.org/. Accessed 9 May 2019.
Shenoy D, Packiananthan S, Chen A, Vijayakumar S. Do African American men need separate prostate cancer screening guidelines? BMC Urol. 2016;16:19.
Vastag B. Government task force discourages routine testing for prostate cancer. The Washington Post. https://www.washingtonpost.com/national/health-science/government-task-force-discourages-routine-testing-for-prostate-cancer/2012/05/21/gIQAhFMFgU_story.html?utm_term=.f763e7e5dfb0, 21 May 2012. Accessed 9 May 2019.
Carter H, Albertsen P, Barry M, et al. Early detection of prostate cancer: AUA guideline. J Urol. 2013;190(2):419–26.
US Preventative Services Task Force, Grossman DC, Curry SJ, et al. Screening for prostate cancer: US Preventative Services Task Force recommendation statement. JAMA. 2018;319(18):1901–13.
Lathan C, Waldman BE, Gagne J, Emmons K. Perspectives of African Americans on lung cancer: a qualitative analysis. Oncologist. 2015;20(4):393–9.
American Cancer Society. Cancer facts & figures for African Americans 2016–2018. Atlanta: American Cancer Society, Inc; 2016.
Ryan B. Lung cancer health disparities. Carcinogenesis. 2018;39(6):741–51.
Tran H, et al. Predictors of lung cancer: noteworthy cell type differences. Perm J. 2013;17:23–9.
Luo J, et al. Environmental carcinogen releases and lung cancer mortality in rural-urban areas of the United States. J Rural Health. 2011;27:342–9.
Katki H, Kovalchik S, Berg C, Cheung L, Chaturvedi A. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA. 2016;315(21):2300–11.
Stead L, Buitrago S, Preciado N, et al. Does advice from doctors encourage people who smoke to quit. Cochrane. https://www.cochrane.org/CD000165/TOBACCO_does-advice-from-doctors-encourage-people-who-smoke-to-quit.
Dhumal G, Pednekar M, Gupta P, et al. Quit history, intentions to quit, and reasons for considering quitting among tobacco users in India: findings from the wave 1 TCP India survey. Indian J Cancer. 2014;51(01):S39–45.
Danesh D, Paskett E, Ferketich A. Disparities in receipt of advice to quit smoking from health care providers: 2010 National Health Interview Survey. Prev Chronic Dis. 2014;11:e131.
Soulakova J, Li J, Crockett L. Race/ethnicity and intention to quit cigarette smoking. Prev Med Rep. 2017;5:160–5.
Kulak J, Cornelius M, Fong G, Giovino G. Differences in quit attempts and cigarette smoking abstinence between whites and African Americans in the United States: literature review and results from the International Tobacco Control US Survey. Nicotine Tob Res. 2016;18(Suppl 1):S79–87.
Alexander L, Trinidad D, Sakuma K, et al. Why we must continue to investigate menthol’s role in the African American smoking paradox. Nicotine Tob Res. 2016;18(Suppl 1):S91–101.
Gandhi K, Foulds J, Steinberg M, Lu S, Williams J. Lower quit rates among African Americans and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract. 2009;63(3):360–7.
Delnevo CD, Gundersen DA, Hrywna M, et al. Smoking-cessation prevalence among U.S. smokers of menthol versus non-menthol cigarettes. Am J Prev Med. 2011;41:357–65.
Nonnemaker J, Hersey J, Homsi G, et al. Initiation with menthol cigarettes and youth smoking uptake. Addiction. 2013;108:171–8.
Henriksen L, Schleicher NC, Dauphinee AL, et al. Targeted advertising, promotion, and price for menthol cigarettes in California high school neighborhoods. Nicotine Tob Res. 2012;14:116–21.
Moreland-Russell S, Harris J, Snider D, et al. Disparities and menthol marketing: additional evidence in support of point of sale policies. Int J Environ Res Public Health. 2013;10:4571–83.
Greenberg AJ, Vachon CM, Rajkumar SV. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia. 2012;26(4):609–14.
Waxman AJ, Mink PJ, Devesa SS, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010;116:5501–6. https://doi.org/10.1182/blood-2010-07-298760.
Kumar S, Fonseca R, Ketterling RP, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 2012;119(9):2100–5.
Greenberg AJ, Philip S, Paner A, et al. Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study. Blood Cancer J. 2015;5:e271. https://doi.org/10.1038/bcj.2014.91.
Landgren O, Rajkumar SV, Pfeiffer RM, et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance (MGUS) among African American and Caucasian women. Blood. 2010;116(7):1056–9.
Costa LJ, Huang JX, Hari PN. Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma. Biol Blood Marrow Transplant. 2015;21(4):701–706.v.
Hari PN, Majhail NS, Zhang MJ, et al. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2010;16:395–402.
Joshua TV, Rizzo JD, Zhang MJ, et al. Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer. 2010;116:3469–76.
Al-Hamadani M, Hashmi SK, Go RS. Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents. Am J Hematol. 2014;89:825.
Fiala MA, Wildes TM. Racial disparities in treatment use for multiple myeloma. Cancer. 2017;123:1590–6.
Biagi JJ, Raphael M, King WD, et al. The effect of delay in time to adjuvant chemotherapy (TTAC) on survival in breast cancer (BC): a systematic review and meta-analysis. ASCO Meet Abstr. 2011;29(15_suppl):1128.
Colleoni M, Bonetti M, Coates AS, The International Breast Cancer Study Group, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. J Clin Oncol. 2000;18(3):584–90.
Kim YW, Choi EH, Kim BR, et al. The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study. Oncotarget. 2017;8(45):80061–72.
Salazar MC, Rosen JE, Wang Z, et al. Association of delayed adjuvant chemotherapy with survival after lung cancer surgery. JAMA Oncol. 2017;3(5):610–9.
Petrelli F, Zaniboni A, Ghidini A, et al. Timing of adjuvant chemotherapy and survival in colorectal, gastric, and pancreatic cancer. A systemic review and meta-analysis. Cancers (Basel). 2019;11(4):Pii: E550. https://doi.org/10.3390/cancers11040550.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hall, G.L. (2020). Important Differences in Cancer Care. In: Patient-Centered Clinical Care for African Americans. Springer, Cham. https://doi.org/10.1007/978-3-030-26418-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-26418-5_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26417-8
Online ISBN: 978-3-030-26418-5
eBook Packages: MedicineMedicine (R0)